Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and II invasive breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 3, 2014, Pages 553-564

  Moran, Meena S ^a   Schnitt, Stuart J ^b   Giuliano, Armando E ^c   Harris, Jay R ^b   Khan, Seema A ^d   Horton, Janet ^e   Klimberg, Suzanne ^f   Chavez Macgregor, Mariana ^g   Freedman, Gary ^h   Houssami, Nehmat ⁱ   Johnson, Peggy L ^j   Morrow, Monica ^k  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j Advocate in Science   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CONSENSUS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MEDICAL ONCOLOGY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; RADIATION ONCOLOGY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84893862531     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.11.012     Document Type: Article

References (72)

1. S. Darby, P. McGale, and C. Correa et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials Lancet 378 2011 1707 1716
2. B. Fisher, S. Anderson, and J. Bryant et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241 (Pubitemid 35176242)
3. M. Azu, P. Abrahamse, and S.J. Katz et al. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates Ann Surg Oncol 17 2010 558 563
4. A. Taghian, M. Mohiuddin, and R. Jagsi et al. Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey Ann Surg 241 2005 629 639 (Pubitemid 40397311)
5. L.E. McCahill, R.M. Single, and E.J. Aiello Bowles et al. Variability in reexcision following breast conservation surgery JAMA 307 2012 467 475
6. M. Morrow, R. Jagsi, and A.K. Alderman et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer JAMA 302 2009 1551 1556
7. T.A. King, R. Sakr, and S. Patil et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy J Clin Oncol 29 2011 2158 2164
8. S. Anderson, I. Wapnir, and J. Dignam et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer J Clin Oncol 27 2009 2466 2473
9. R. Graham, M. Mancher, and D.M. Wolman et al. Clinical Practice Guidelines We Can Trust 2011 National Academies Press Washington, DC
10. F. Sardanelli, F. Podo, and F. Santoro et al. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study): Final results Invest Radiol 46 2011 94 105
11. D. Moher, A. Liberati, and J. Tetzlaff et al. Preferred reporting items for systematic reviews and meta-snalyses: The PRISMA statement J Clin Epidemiol 62 2009 1006 1012
12. N. Houssami, P. Macaskill, and M.L. Marinovich et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy Eur J Cancer 46 2010 3219 3232
13. Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early stage invasive breast cancer treated with breast conserving therapy: A metaanalysis. Ann Surg Oncol. In press.
14. J.R. Bellon, S.E. Come, and R.S. Gelman et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial J Clin Oncol 23 2005 1934 1940 (Pubitemid 46211372)
15. A.C. Voogd, M. Nielsen, and J.L. Peterse et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697 (Pubitemid 32230869)
16. D.E. Wazer, R.K. Schmidt-Ullrich, and R. Ruthazer et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed Int J Radiat Oncol Biol Phys 40 1998 851 858 (Pubitemid 28150803)
17. C.M. Mansfield, L.T. Komarnicky, and G.F. Schwartz et al. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy Cancer 75 1995 2328 2336
18. H. Bartelink, J.C. Horiot, and P.M. Poortmans et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265 (Pubitemid 47325610)
19. H.A. Jones, N. Antonini, and A.A. Hart et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: A subgroup analysis of the EORTC boost versus no boost trial J Clin Oncol 27 2009 4939 4947
20. M. Mannino, and J.R. Yarnold Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol 90 2009 14 22
21. R. Holland, S.H. Veling, and M. Mravunac et al. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery Cancer 56 1985 979 990 (Pubitemid 15003474)
22. R.A. Graham, M.J. Homer, and J. Katz et al. The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer Am J Surg 184 2002 89 93 (Pubitemid 34880211)
23. A.J. Guidi, J.L. Connolly, and J.R. Harris et al. The relationship between shaved margin and inked margin status in breast excision specimens Cancer 79 1997 1568 1573 (Pubitemid 27154789)
24. D. Carter Margins of "lumpectomy" for breast cancer Hum Pathol 17 1986 330 332
25. B. Fisher, J.H. Jeong, and S. Anderson et al. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: Updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials J Natl Cancer Inst 96 2004 1823 1831 (Pubitemid 40089466)
26. E.P. Mamounas, S.J. Anderson, and J.J. Dignam et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 J Clin Oncol 30 2012 3960 3966
27. D. Hind, S. Ward, and E. De Nigris et al. Hormonal therapies for early breast cancer: Systematic review and economic evaluation Health Technol Assess 11 2007 1 134 iii-iv, ix-xi
28. I. Smith, M. Procter, and R.D. Gelber et al. 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial Lancet 369 2007 29 36 (Pubitemid 46039831)
29. E.H. Romond, E.A. Perez, and J. Bryant et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684 (Pubitemid 41464706)
30. N.D. Arvold, A.G. Taghian, and A. Niemierko et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy J Clin Oncol 29 2011 3885 3891
31. K.D. Voduc, M.C. Cheang, and S. Tyldesley et al. Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
32. C. Mazouni, F. Rimareix, and M.C. Mathieu et al. Outcome in breast molecular subtypes according to nodal status and surgical procedures Am J Surg 205 2013 662 667
33. B.G. Haffty, Q. Yang, and M. Reiss et al. Locoregional relapse and distant metastasis in conservatively managed triple-negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657 (Pubitemid 46631305)
34. G.M. Freedman, P.R. Anderson, and T. Li et al. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
35. A. Gangi, A. Chung, J. Mirocha, D.Z. Liou, T. Leong, and A.E. Giuliano Breast-Conserving Therapy for Triple-Negative Breast Cancer JAMA surg 2014 Jan 1 [Epub ahead of print] http://dx.doi.org/10.1001/jamasurg.2013.3037
36. M.L. Pilewskie Effect of margin width on local recurrence (LR) in triple-negative breast cancer treated with breast-conserving surgery (BCT) J Clin Oncol 31 15S 2013 54
37. B.S. Abdulkarim, J. Cuartero, and J. Hanson et al. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy J Clin Oncol 29 2011 2852 2858
38. A.Y. Ho, G. Gupta, and T.A. King et al. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy Cancer 118 2012 4944 4952
39. F.C. Adkins, A.M. Gonzalez-Angulo, and X. Lei et al. Triple-negative breast cancer is not a contraindication for breast conservation Ann Surg Oncol 18 2011 3164 3173
40. S.C. Formenti, D. Gidea-Addeo, and J.D. Goldberg et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue J Clin Oncol 25 2007 2236 2242 (Pubitemid 46954649)
41. E. Donovan, N. Bleakley, and E. Denholm et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy Radiother Oncol 82 2007 254 264 (Pubitemid 46341474)
42. S.C. Formenti, J.K. DeWyngaert, and G. Jozsef et al. Prone vs supine positioning for breast cancer radiotherapy JAMA 308 2012 861 863
43. J.P. Pignol, I. Olivotto, and E. Rakovitch et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis J Clin Oncol 26 2008 2085 2092
44. J. Haviland, R. Agrawal, and E. Aird et al. The UK START (Standardisation of Breast Radiotherapy) trials: 10-Year follow-up results [abstract S4-1] Cancer Res 72 Suppl. 2012 24
45. T.J. Whelan, J.P. Pignol, and M.N. Levine et al. Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 2010 513 520
46. S.M. Bentzen, R.K. Agrawal, and E.G. Aird et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial Lancet Oncol 9 2008 331 341
47. S.M. Bentzen, R.K. Agrawal, and E.G. Aird et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial Lancet 371 2008 1098 1107
48. C. Polgár, J. Fodor, and Z. Orosz et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: First results of the randomized Budapest Boost Trial Strahlenther Onkol 178 2002 615 623 (Pubitemid 35390398)
49. P. Romestaing, Y. Lehingue, and C. Carrie et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France J Clin Oncol 15 1997 963 968 (Pubitemid 27106278)
50. L. Livi, I. Meattini, and D. Franceschini et al. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy Radiother Oncol 108 2013 273 278
51. A.C. Neuschatz, T. DiPetrillo, and H. Safaii et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy Cancer 97 2003 30 39 (Pubitemid 36033860)
52. C. Murphy, P.R. Anderson, and T. Li et al. Impact of the radiation boost on outcomes after breast-conserving surgery and radiation Int J Radiat Oncol Biol Phys 81 2011 69 76
53. N. Biglia, F. Maggiorotto, and V. Liberale et al. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) Eur J Surg Oncol 39 2013 455 460
54. M.A. Chung, B. Cole, and H.J. Wanebo et al. Optimal surgical treatment of invasive lobular carcinoma of the breast Ann Surg Oncol 4 1997 545 550 (Pubitemid 127725500)
55. D.J. Winchester, H.R. Chang, and T.A. Graves et al. A comparative analysis of lobular and ductal carcinoma of the breast: Presentation, treatment, and outcomes J Am Coll Surg 186 1998 416 422 (Pubitemid 28169363)
56. V. Galimberti, P. Maisonneuve, and N. Rotmensz et al. Influence of margin status on outcomes in lobular carcinoma: Experience of the European Institute of Oncology Ann Surg 253 2011 580 584
57. A.R. Sasson, B. Fowble, and A.L. Hanlon et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation Cancer 91 2001 1862 1869 (Pubitemid 32424112)
58. R.M. Ciocca, T. Li, and G.M. Freedman et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy Ann Surg Oncol 15 2008 2263 2271
59. M. Moran, and B.G. Haffty Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapy Int J Radiat Oncol Biol Phys 40 1998 353 358 (Pubitemid 28114380)
60. E. Downs-Kelly, D. Bell, and G.H. Perkins et al. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ Arch Pathol Lab Med 135 2011 737 743
61. E.R. Fisher, S. Anderson, and E. Tan-Chiu et al. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06 Cancer 91 Suppl. 2001 1679 1687 (Pubitemid 32319246)
62. G.H. de Bock, J.A. van der Hage, and H. Putter et al. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies Eur J Cancer 42 2006 351 356 (Pubitemid 43132890)
63. A. Taghian, J. Jeong, and E. Mamounas et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five national Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 22 2004 4247 4254 (Pubitemid 41185145)
64. N. Kroman, H. Holtveg, and J. Wohlfahrt et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma Cancer 100 2004 688 693 (Pubitemid 38176844)
65. C.K. Anders, D.S. Hsu, and G. Broadwater et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 2008 3324 3330
66. G. Cancello, P. Maisonneuve, and N. Rotmensz et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer Ann Oncol 21 2010 1974 1981
67. S. Demirci, G. Broadwater, and L.B. Marks et al. Breast conservation therapy: The influence of molecular subtype and margins Int J Radiat Oncol Biol Phys 83 2012 814 820
68. A.H. Partridge, S. Gelber, and M.J. Piccart-Gebhart et al. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: Results from a herceptin adjuvant trial J Clin Oncol 31 2013 2692 2698
69. S.J. Schnitt, J.L. Connolly, and J.R. Harris et al. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy Cancer 53 1984 1049 1057 (Pubitemid 14196481)
70. S.J. Schnitt, J.L. Connolly, and U. Khettry et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy Cancer 59 1987 675 681 (Pubitemid 17018739)
71. R. Holland, J.L. Connolly, and R. Gelman et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast J Clin Oncol 8 1990 113 118 (Pubitemid 20032453)
72. S.J. Schnitt, A. Abner, and R. Gelman et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy Cancer 74 1994 1746 1751 (Pubitemid 24301829)